SUSCEPTIBILITY OF HELICOBACTER-PYLORI TO SIMETHICONE AND OTHER NON-ANTIBIOTIC DRUGS

Citation
R. Ansorg et al., SUSCEPTIBILITY OF HELICOBACTER-PYLORI TO SIMETHICONE AND OTHER NON-ANTIBIOTIC DRUGS, Journal of antimicrobial chemotherapy, 37(1), 1996, pp. 45-52
Citations number
29
Categorie Soggetti
Microbiology,"Pharmacology & Pharmacy","Infectious Diseases
ISSN journal
03057453
Volume
37
Issue
1
Year of publication
1996
Pages
45 - 52
Database
ISI
SICI code
0305-7453(1996)37:1<45:SOHTSA>2.0.ZU;2-4
Abstract
The antifoaming agent simethicone (Lefax), the protease inhibitor gabe xate mesilate (FOY), the antimycotic ketoconazole, and the hydroxyl sc avangers dimethylsulphoxide (DMSO) and allopurinol were investigated f or growth inhibition of Helicobacter pylori and representative strains of other bacterial species. H. pylori were selectively inhibited by 6 4-128 mg/L of simethicone, 64-128 mg/L gabexate mesilate, and 16-64 mg /L ketoconazole. Dimethylsulphoxide and allopurinol showed no antibact erial effect at concentrations used therapeutically. It is concluded t hat gabexate mesilate, ketoconazole and, particularly, simethicone are candidates for treatment of H. pylori infection.